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Abstract
The development of next generation sequencing (NGS) technology and genotype
imputation methods enabled researchers to measure both common and rare variants
in genome-wide association studies (GWAS). Statistical methods have been proposed
to test a set of genomic variants together to detect if any of them is associated with
the phenotype or disease. In practice, within the set of variants, there is an unknown
proportion of variants truly causal or associated with the disease. Because most de-
veloped methods are sensitive to either the dense scenario, where a large proportion
of the variants are associated, or the sparse scenario, where only a small proportion of
the variants are associated, there is a demand of statistical methods with high power
in both scenarios. In this paper, we propose a new association test (weighted Adap-
tive Fisher, wAF) that can adapt to both the dense and sparse scenario by adding
weights to the Adaptive Fisher (AF) method we developed before. Using both simu-
lation and the Genetic Analysis Workshop 16 (GAW16) data, we have shown that the
new method enjoys comparable or better power to popular methods such as sequence
kernel association test (SKAT and SKAT-O) and adaptive SPU (aSPU) test.
Keywords: Association Analysis, Adaptive Fisher, Rare Variants, Common Variants
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Introduction
Single nucleotide variants (SNVs) are a type of chromosome variants where the DNA se-
quence of an individual is different from the reference genome on only one nucleotide. Before
the era of next generation sequencing (NGS), SNP array technology was used to obtain
the genotypes of common SNVs with minor allele frequencies (MAFs) larger than certain
cutoff (e.g. 1% or 5%, a.k.a single nucleotide polymorphisms or SNPs). Over the past
decades, genome-wide association studies (GWASs) have been successfully conducted to dis-
cover many disease-associated common SNVs with relatively large minor allele frequencies
(MAFs) [Welter et al., 2013, MacArthur et al., 2016]. Despite the success of GWAS, the
common SNVs detected through this procedure sometimes account for only a small propor-
tion of the heritability, which is know as the problem of “missing heritability” [Manolio et al.,
2009]. This problem promotes the researchers to seek heritability outside of the controversial
common disease-common variant hypothesis, which is the fundamental of GWAS based on
common SNVs, but to seek “missing heritability” in rare SNVs Schork et al. [2009]. Rare
SNVs (a.k.a rare variants) are SNVs with low MAFs (often < 1% or < 5%). Comparing
to common SNVs, the number of rare SNVs is much larger, and their locations on the hu-
man genome is often unknown before genotyping all the study samples, which makes DNA
hybridization-based genotyping technology (e.g. SNP array) inapplicable in genotyping of
rare SNVs. Thanks to the advent of NGS, researchers now are enabled to reliably measure
rare SNVs. Furthermore, because of the development of fast imputation tools [Das et al.,
2016] and the 1000 Genomes project [Consortium et al., 2015], rare SNVs can be imputed
for old GWASs where only common SNVs were measured. This helps recycle and add value
to the numerous GWASs that are conducted for many complex human diseases and are
available on public domain.
However, the technology advancement in genotyping of rare SNVs also presents several
statistical challenges for the association analysis method development. First, because of the
small MAFs of the rare variants, the statistical power of traditional association methods are
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very low when applied to detect association between rare variants and the disease outcome.
Second, because the number of SNVs including both common and rare variants are signifi-
cantly larger than the number of common variants (often more than 100 times larger), the
multiple comparison issue is more severe [Song and Zhang, 2014]. Therefore, it would be
powerless if association analysis were performed on each single SNV separately. A commonly
used solution to these issues was to perform the association analysis on SNV sets, where mul-
tiple SNVs grouped together based on their locations on the genome. SNVs on or close to
a gene are often grouped together into one SNV set. However, the traditional statistical
testing methods such as score test or likelihood ratio test used in multivariate generalized
linear model (GLM) are not powerful enough when many variants are included in the SNV
set. As shown by Fan [1996], the tests based on χ2 distribution will have no power when
the signal is weak or rare as the degree of freedom increases. To solve this problem, three
categories of approaches have been proposed, all of them essentially reduced the degree of
freedom in some way to boost the statistical power.
The first category is burden tests, which collapse rare variants into genetic burdens,
then test the effects of the genetic burden. CAST [Morgenthaler and Thilly, 2007], CMC
[Li and Leal, 2008] and wSum [Madsen and Browning, 2009] all belong to this category. By
combining multiple rare variants into a single measurement of genetic burden, these methods
essentially reduced the number of parameters to test down to one, which is equivalent to
reducing the degree of freedom of the χ2 test statistic to one. Despite the popularity of
this type of methods, the traditional way of calculating genetic burden often ignores the
fact that different variants may have opposite effects on the same outcome. Simply pooling
or summing the variants together may cause the opposite effects to cancel out, therefore
reduce the statistical power. A solution is to calculate genetic burden adaptively based on
evidence provided by the data. For example, Price et al. [2010] proposed to adjust minor
allele frequency (MAF) threshold for the pooling step based on data. Han and Pan [2010]
and Hoffmann et al. [2010] proposed to adaptively choose the sign and magnitude of the
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weight in the collapsing step to calculate genetic burdens. TARV [Song and Zhang, 2014]
can also be viewed as this type of method because it adaptively combines multiple variants
into a “super variant” based on the strength of evidence provided by each single variant.
The second category of methods is quadratic tests which often base on test of variance
component in mixed effect models. The well-known SKAT [Wu et al., 2011] belongs to
this category. By assuming the effect of each variant being random, SKAT tests whether
the variance of the random effects is zero. The test statistic can be approximated by a
χ2 distribution with a degree of freedom much smaller than the degree of freedom in the
likelihood ratio test (or Rao’s score test) in the fixed effect models. SKAT can also test
non-linear effects by adopting an arbitrary kernel matrix. SKAT was also extended to
accommodate multiple candidate kernels [Wu et al., 2013], to jointly test rare and common
variants [Ionita-Laza et al., 2013], and to apply on family data [Chen et al., 2013]. Some
other popular methods, such as C-alpha [Neale et al., 2011] and SSU [Pan, 2009] can be
viewed as special cases of SKAT.
The third category is functional analysis. Because the genomic variants within the same
gene are often highly correlated due to linkage disequibrillium (LD), this category of methods
treat them as discrete realizations of a hidden continuous function on the genome. Both the
variants and their coefficients can then be decomposed in the functional space. Since the
number of functional bases used is generally smaller than the number of variants, this is
equivalent to a dimensional reduction method which also reduces the degree of freedom
of the association test. Different methods under this category has been proposed utilizing
different basis including functional principle component basis [Luo et al., 2011], B-spline
basis [Luo et al., 2012, Fan et al., 2013], and Fourier basis [Fan et al., 2013].
In addition to these three categories of methods, effort has also been made to combine
multiple testing methods into one single test. For example, the popular SKAT-O [Lee et al.,
2012] is a combination of variance component test (SKAT) and burden test. Similarly,
Derkach et al. [2013] proposed to combine variance component test and burden test using
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Fisher’s method or minimal P-value.
It should be noted that the power of aforementioned methods relies on the proportion of
variants which truly associate with the disease outcome. Under the alternative hypothesis –
when the null hypothesis of no association is untrue, all three types of methods assume that
every SNVs included in the test has some nonzero effect more or less. Specifically, burden
tests assume the effects of the variants are proportional to each other, with the proportion
predefined by the weights used to calculate the genetic burden; variance component tests
assume the random effects of the combined variants share a common variance component,
which if is not zero implies all the random effects are nonzero; and the functional analysis
based methods, tests whether any functional basis (a weighted sum of variants) has a nonzero
effect, which in turn implies nonzero effects for all or most of the variants. The type I error
of these methods is not affected by violation of this assumption of alternative hypothesis,
which does not undermine their validity. However, under alternative hypothesis where not all
of the effects are nonzero, especially when only a small proportion of variants have nonzero
effects, the statistical power of these tests will be suboptimal. Therefore there is a demand
for statistical methods that can adapt to the proportion of variants with nonzero effects.
For the ease of discussion, we call the scenario where this proportion is large as the dense
scenario, and call the scenario where this proportional is small as the sparse scenario. For
this purpose, Pan et al. [2014] proposed an adaptive test named aSPU which has strong
statistical power in both the dense and sparse scenarios. This aSPU can also be viewed as
a combination of SKAT (with linear kernel) and other tests including burden test. Barnett
and Lin [2014] suggested that Higher Criticism (HC) can be another potential powerful test
that can adaptively detect both dense and sparse signals. Previously, we proposed Adaptive
Fisher (AF) method Song et al. [2016] and illustrated in simulation that AF is a very powerful
method to detect the mixture distribution in both dense and sparse scenarios, and it can be
much more powerful than HC with finite sample. Therefore, we propose to use AF to detect
disease associated SNV sets, and compare to existing methods in the following section.
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Methods
Suppose a trait for n independent subjects Y = (Yi1, ..., Yin)
T are observed. Gi = (Gi1, ..., GiK)
T
denotes the genotypes of K SNVs in a chromosomal region (e.g. a gene) for subject i, where
Gik = 0, 1, 2 represents the number of minor alleles at locus k of subject i. We model
associations between the trait and SNVs with the following generalized linear model
h
(
E(Yi)
)
= β0 +
K∑
k=1
βkGik, (1)
where β = (β1, ..., βK)
T is the vector of SNV effects, and vector α = (α1, ..., αJ)
T contains
covariate effects. h(·) is taken as the logit link function for binary traits (e.g. diseased or
nondiseased) or the identity link function for continuous traits (e.g. blood pressure, height,
etc.). If J covariates Ci = (Ci1, ..., CiJ)
T , i = 1, 2, ..., n are also observed for each subject,
the model can be extended as
h
(
E(Yi)
)
= β0 +
K∑
k=1
βkGik +
J∑
j=1
αjCij (2)
Determining whether there is an association between the trait and any SNV is equivalent to
testing the following hypotheses,
H0 : β = 0 versus H1 : β 6= 0. (3)
The proposed adaptive fisher tests involve the score statistics U = (U1, ..., UK)
T . For
model (1),
U =
n∑
i=1
(Yi − Y¯ )Gi (4)
and its estimated covariance matrix under H0 is given by
V = Ĉov(U |H0) = Y¯ (1− Y¯ )
n∑
i=1
(Gi − G¯)(Gi − G¯)T . (5)
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for the binary traits, and
V = Ĉov(U |H0) = σˆ21
n∑
i=1
(Gi − G¯)(Gi − G¯)T (6)
for the continuous traits, where Y¯ = 1
n
∑n
i=1 Yi, σˆ
2
1 =
1
n−1
∑n
i=1(Yi−Y¯ )2 and G¯ = (G¯·1, ..., G¯·K)T
with G¯·k = 1n
∑n
i=1Gik. For model (2),
U =
n∑
i=1
(Yi − µˆYi)(Gi − Gˆi), (7)
for the binary traits,
V = Ĉov(U |H0) = σˆ22
n∑
i=1
(Gi − Gˆi)(Gi − Gˆi)T , (8)
and for the continuous traits,
V = Ĉov(U |H0) = σˆ23
n∑
i=1
(Gi − Gˆi)(Gi − Gˆi)T , (9)
where µˆYi = h
−1(βˆ0 +
∑J
j=1 αˆjCij) with βˆ0 and αˆj, j = 1, 2, ..., J being the maximum
likelihood estimators, Gˆi = (Gˆi1, ..., Gˆik) with Gˆik being the predictive value of Gik from a
linear regression model with covariates as predictors, σˆ22 =
1
n
∑n
i=1(µˆYi(1 − µˆYi), and σˆ23 =
1
n−1
∑n
i=1(Yi − µˆYi)2.
Adaptive Fisher Method
Let the standardized score statistics be U˜k = Uk/
√
Vkk, where Vkk is the k
th diagonal element
of V . If βk is tested marginally, the P-value for this marginal score test is pk = 2
(
1−Φ(|U˜k|)
)
,
k = 1, 2, ..., K, as U˜k is asymptotically N(0, 1) distributed under H0. Let
Rk = − log pk. (10)
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Order R’s in descending order R(1) ≥ · · · ≥ R(K). Let S = (S1, ..., SK)T be the partial sums
of R(1), ..., R(K),
Sk =
k∑
l=1
R(l). (11)
For each Sk, k = 1, 2, ..., K, we calculated its P-value by
Psk = Pr(Sk ≥ sk), (12)
where sk is be observed value of Sk. The AF test is based on the AF statistic below
TAF = min
1≤k≤K
Psk . (13)
Weighted Adaptive Fisher Method
SNVs can be weighed differently when taking the partial sums. Suppose w = (w1, ..., wK)
are weights of the K SNVs in a genetic region. Define
Xk = wkRk. (14)
Order X1, ..., XK in descending order X(1), ..., X(K). Let S
∗ = (S∗1 , ..., S
∗
K)
T be the partial
sums of X(1), ..., X(K)
S∗k =
k∑
l=1
X(l). (15)
Similar to (12), the P-value of s∗k (observed value of S
∗
k), Ps∗k = Pr(S
∗
k ≥ s∗k), and the weighted
AF (wAF) statistic is defined by
TwAF = min
1≤k≤K
Ps∗k . (16)
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Computation
The following permutation procedure is needed for accessing Psk (Ps∗k) in (12) and finding
the null distributions of TAF in (13) and TwAF in (16). Here the weighted version for model
(1) is used as an example. The unweighted method can be treated as a special case of all
weights being equal.
1. Calculate residuals by ei = Yi − Y¯ , i = 1, 2, ..., n.
2. Permute ei’s for a large number B times to obtain e
(b) = (e
(b)
1 , ..., e
(b)
n )T , b = 1, 2, ..., B
where (e
(b)
1 , ..., e
(b)
n )T is a permutation of e(0) = (e1, ..., en)
T .
3. For each e(b), calculate U (b) = (U
(b)
1 , ..., U
(b)
K )
T =
∑n
i=1 eiGi and p
(b) = (p
(b)
1 , ..., p
(b)
K )
T
with p
(b)
k = 2
(
1 − Φ(|U (b)k /
√
Vkk|)). Then follow equations (10), (14) and (15) to get
S∗(b) = (S∗(b)1 , ..., S
∗(b)
K )
T , b = 0, 1, 2, .., B.
4. For a fixed b∗ ∈ {0, 1, 2, ...B},
P
(b∗)
S∗k
=
1
B + 1
B∑
b=0
I{S∗(b)k ≥ S∗(b
∗)
k }.
5. For each S∗(b), T (b)wAF = min1≤k≤K P
(b)
S∗k
, b = 0, 1, 2, ..., B.
6. The P-value of wAF test can be approximated by
P̂r{TwAF ≤ T (0)wAF|H0} =
1
B + 1
B∑
b=1
I{T (b)wAF ≤ T (0)wAF}
where T
(0)
wAF = min1≤k≤K P
(0)
S∗k
is the observed value of the wAF statistic and I(·) is the
indicator function.
The above procedure applies to model (2) as well, with ei being replaced by ei = Yi − µˆYi ,
i = 1, 2, ..., n as the only change.
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Results
We evaluate our wAF method using both simulation and the Genetic Analysis Workshop 17
(GAW17) data. The performance of our method is compared to SKAT, SKAT-O, aSPU and
Min-P (which takes the minimal P-value of all the combined variants as the test statistic).
Simulation Studies
Simulation studies are conducted to evaluate the performance of wAF test under both dense
and sparse scenarios. The simulation analysis was performed following the simulation frame-
work of Pan et al. [2014].
First, genotypes Gi = (Gi1, ..., GiK)
T , i = 1, 2, ..., n are simulated by the following steps,
similar to the simulation setups in Pan et al. [2014].
1. Generate Z1 = (Z11, ..., Z1K)
T and Z2 = (Z21, ..., Z2K)
T independently from a multi-
variate normal distribution N(0,A). A has a first-order autoregressive (AR(1)) co-
variance structure with the (k, k′)th element Akk′ = c|k−k
′|. c is chosen to be 0.9 to give
close loci a higher correlation and distant loci a lower correlation.
2. Randomly sample the minor allele frequencies (MAF’s) by first generating log(MAF)’s
from U(log(0.001), log(0.05)) and then exponentiating them back to MAFs.1 Set Gik =
I(Φ(Z1k) ≤ MAFk) + I(Φ(Z2k) ≤ MAFk), k = 1, ..., K.
3. Repeat step 1 and 2 n times to generate genotypes for all subjects.
For genotype effects β = (β1, ..., βK)
T , randomly sample piK effects to be nonzero, whose
values are sampled from a uniform distribution within [−δ, δ], while keep the other (1−pi)K
effects remain zeros. Trait of n = 1, 000 subjects are generated from model (1).
The weights of the wAF test are chosen to be wk =
√
MAFk(1−MAFk), k = 1, 2, .., K.
The weights of SKAT and SKAT-O are chosen to be flat with wk = 1, k = 1, 2, ..., K, so
1Because of the logarithm, this MAF sampling algorithm often samples small MAF’s and therefore yields
more rare variants.
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that SKAT is equivalent to SSU Wu et al. [2011]. The significance level is set to be 0.05 for
every test. All simulation results are based on 5, 000 replicates.
Binary Traits
When generating binary trait, h(·) is taken to be the logit link function. We increase the
number of SNVs, K, from 50 to 500 with an increment 50, while hold the effect proportion
pi and the effect size δ constant. For the dense scenario, pi = 20% and δ = 0.25. For the
sparse scenario, pi = 2% and δ = 1. Figure 1 shows that the wAF test results in large powers
for the both dense and sparse scenarios. Specifically, in the dense scenario, wAF and SKAT
have the highest power. SKAT-O and aSPU are slightly less powerful than SKAT and wAF.
Min-P, on the other hand, is much less powerful than the other methods. For the sparse
scenario, Min-P is the most powerful method. Our wAF has the second highest power which
is about 5% to 10% higher than the other methods including SKAT, SKAT-O and aSPU.
For all these compared methods, the type I errors are well-controlled empirically as shown
in the supplementary table 1.
Continuous Traits
When generating continuous trait, h(·) is taken to be the identity link function and random
errors are standard normal random variables. Again, K is increased from 50 to 500 with
an increment 50, while pi and δ are held constants. For the dense scenario, pi = 20% and
δ = 0.15. For the sparse scenario, pi = 2% and δ = 0.5. Based on power curves in Figure 2,
the wAF test performs relatively well for the both dense and sparse scenarios similar to what
we have seen in the binary trait. In dense scenario, wAF and SKAT enjoys the highest power,
which is slightly better than aSPU and SKAT-O, and much better than Min-P. Whereas in
the sparse scenario, Min-P is the most powerful method, seconded by wAF, and wAF has
higher power than aSPU, SKAT and SKAT-O. Similar to the binary traits, all type I errors
are well-controlled empirically as seen in the supplementary table 1.
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Figure 1: Comparison of empirical powers of five methods for binary trait. (a) Power against
varying number of loci K in the dense scenario with effect proportion pi = 20% and effect size
δ = 0.25. K varies from 50 to 500. (b) Power against varying number of loci K in the sparse
scenario with effect proportion pi = 2% and effect size δ = 1. K varies from 50 to 500.
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Figure 2: Comparison of empirical powers of five methods for continuous trait. (a) Power against
varying number of loci K in the dense scenario with effect proportion pi = 20% and effect size
δ = 0.15. K varies from 50 to 500. (b) Power against varying number of loci K in the sparse
scenario with effect proportion pi = 2% and effect size δ = 0.5. K varies from 50 to 500.
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Table 1: Estimated Power for Some Causal Genes
Gene wAF aSPU SKAT SKATO Min-P
PIK3C2B 0.440 0.625 0.430 0.575 0.270
BCHE 0.245 0.210 0.155 0.145 0.165
KDR 0.360 0.295 0.385 0.400 0.050
VNN1 0.275 0.255 0.195 0.180 0.155
INSIG1 0.015 0.015 0.225 0.225 0.000
LPL 0.135 0.125 0.120 0.105 0.055
PTK2B 0.065 0.070 0.065 0.085 0.110
PLAT 0.145 0.145 0.120 0.180 0.060
VLDLR 0.110 0.085 0.100 0.085 0.090
SIRT1 0.110 0.090 0.095 0.090 0.035
VWF 0.060 0.020 0.015 0.030 0.135
FLT1 0.155 0.115 0.140 0.160 0.045
SOS2 0.270 0.220 0.270 0.210 0.100
HSP90AA1 0.345 0.145 0.255 0.190 0.290
SREBF1 0.105 0.075 0.075 0.070 0.105
PRKCA 0.030 0.030 0.185 0.185 0.000
RRAS 0.150 0.185 0.135 0.240 0.070
Application to GAW17 data
The above five methods (wAF, aSPU, SKAT, SKAT-O and Min-P) are applied to Genetic
Analysis Workshop 17 (GAW17) mini-exome simulation data in Almasy et al. (2011) Almasy
et al. [2011]. 24, 487 SNVs in 3, 205 genes from 697 subjects are genotyped. If only rare
variants (with MAFs no larger than 1%) are considered, there are 18, 131 rare variants in
2, 476 genes (that contain at least 1 rare variant). 200 sets of binary traits are simulated
based on genotypes and three covariates: age, gender and smoking status. When only rare
variants are considered, 35 causal genes have effects on the trait.
We follow the same procedure as Pan et al. [2014]. We apply the five tests on each of the
causal genes separately with gene-wise significance level 0.05, and estimate the corresponding
powers, using the 200 sets of phenotypes. Removing genes for which all tests have power
lower than 10%, the estimated powers for the remaining 17 genes are shown in Table 1.
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Discussion
Association analysis of SNV sets becomes the standard analysis approach in GWAS when
rare variants are genotyped or imputed in the dataset. However, when many SNVs are
combined together into one omnibus test, the power of the statistical test often depends on
the proportion of variants with nonzero effects and how these variants are combined. Most
current methods except aSPU is not adaptive to this proportion and only applies to either
the dense or sparse scenario. In this paper, we proposed a new adaptive method wAF as an
alternative to aSPU with better or comparable power. Based on simulation, we can see that
for both dense and sparse scenarios, wAF outperformed aSPU in terms of statistical power
for either binary or continuous outcome. In the analysis of GAW17 data, we found that
wAF sometimes outperformed and sometimes underperformed comparing to aSPU. This is
because in GAW17, the datasets were simulated such that all of the rare variants are risk
factors, which means that the minor alleles always increase the risk of disease. By having the
SNVs with effects of the same direction (increase risk), burden tests become more favorable
than variance component tests. As shown by Pan et al. [2014], SPU tests with odds powers
take into account the direction of the effect, which can be considered as various types of
burden tests. Therefore, aSPU may enjoy the high power of burden tests, hence performed
better than wAF in some genes of GAW17. To improve the power for this situation when
all or most of the causal variants have the same effect direction, we can use wAF to combine
(1) the 2-sided P-values (as shown in this paper), (2) the 1-sided P-values on whether the
variants are risk factors and (3) the 1-sided P-values on whether the variants are protective.
Then use the minimal P-value of (1), (2) and (3) as our test statistic. However, because this
alteration is very trivial and to avoid distracting the readers from our major methodology,
we only illustrated (1) in this paper.
As stated in introduction, HC is another methods that can be used to combine marginal
tests of each variant. Although we did not explore the application of HC in SNV set analysis,
Barnett et al. [2017] proposed a generalized higher criticism (GHC) based on HC. They found
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that GHC was only powerful in sparse scenario but underperformed in dense scenario, and
suggested that one may consider combining GHC and SKAT to boost power when we do not
know which scenario the causal gene actually belongs to, which we believe is almost true for
every real life problem. This conclusion agrees with our previous findings about HC [Song
et al., 2016].
While comparing wAF and aSPU, we found that their test statistics can be written in
the same general format. For both methods, we can think the test statistic as adaptively
chosen from a set of weighted sums with different weights. The weighted sums in both
methods can be written as
∑
k vc(U˜k, Gk)w(Gk)f(U˜k), where vc(U˜k, Gk) is the cth adaptive
weight function depends on the standardized score statistic and the genotype data for variant
k, w(Gk) is a non-adaptive weight only depends on the genotype data, and f(U˜k) is a
transformation of the standardized score statistic. We can show that for aSPU, f(U˜k) = U˜k,
w(Gk) = sd(Gk), and vc(U˜k, Gk) = [w(Gk)f(U˜k)]
(c−1) for c ∈ {1, 2, . . . , 8,∞}; for wAF,
f(U˜k) = 2[1 − Φ(|U˜k|)], w(Gk) =
√
MAFk(1−MAFk) ≈ sd(Gk)/
√
2, and vc(U˜k, Gk) =
I{w(Gk)f(U˜k) ≥ [w(G)f(U˜)](c)} for c ∈ {1, 2, . . . , K}, where I{·} is an indicator function
[·](c) denotes the cth largest order statistics of the quantity inside the bracket. By comparison,
we can see that the major difference between aSPU and wAF is how we adaptively weight the
test statistic: aSPU creates the weight by raising the statistics to different power, whereas
wAF sequentially put a 0/1 weight based on the magnitude of the test statistics. This
comparison also reveals that although not explicitly mentioned, aSPU also weighs different
variants based on their MAF using almost the same weight as we used in wAF.
Because permutation is needed for wAF, computational burden is a major weakness.
To improve computation speed, we adopt the same strategy as Pan et al. [2014] to run a
hundred permutation first, then choose to increase number of permutation only for those
with small P-values. Theoretically, because sorting and order statistics are used in wAF,
the computation complexity is higher than aSPU. Specifically, because wAF need sorting
and cumulative summation, our complexity is higher than aSPU by an order of logK. In
16
practice, because K is often fixed, the theoretical difference in computational complexity can
be ignored. In our future work, we plan to improve the computation of wAF by importance
sampling.
In conclusion, we developed wAF, a powerful statistical method for SNV set associa-
tion analysis that performs better than current available methods in both dense and sparse
scenarios.
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